INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

CLINICAL TRIAL TECHNOLOGY SOLUTIONS

  • What can 22,000 people with an AI-mindset accomplish?

    Speed without shortcuts

    AI in clinical development at Parexel enables our teams to surface predictive insights at every stage, reducing protocol risk, study delays, and costly trial amendments.

    Parexel's approach to AI in clinical development is built on the Precision Pathway, a strategic operating model that embeds AI across the full trial lifecycle. AI empowers our teams at critical decision points to:

    1. Simplify complex tasks to accelerate timelines: AI capabilities are delivering up to 50% cycle time reductions in IND submission generation.
    2. Apply insights with agility to enable better decision-making
    3. Enhance data handling to drive first-time quality through content generation and workflow automation
  • See how integrated eConsent, IRT, and eCOA work together to improve study quality, accelerate decision making, and reduce site and sponsor burden.

  • Improve study quality, accelerate decision making, and reduce site and sponsor burden by using IQVIA’s integrated Interactive Response Technology and electronic Clinical Outcome Assessment solution.

  • With over 15 years of RTSM experience, high-touch quality management, and forward-thinking technology, our solutions enhance trial speed, accuracy, and operational efficiency.

  • From enabling connected clinical trials to supporting digital therapy management, our solutions help improve clinical trial operational efficiency and data quality, strengthen commercial success, and empower patients to self-manage their therapy.